week 45 check-in — 21kg down, sulphur burps manageable, one thing confusing me
week 45 check-in — 21kg down, sulphur burps manageable, one thing confusing me. Numbers below. Ask me the boring questions, they are the useful ones. Figures up front so nobody has to dig: week 45 and 21kg. Why this compound is not simply another agonist, which is how it gets described everywhere else. Amylin is…
Combination and monotherapy arms must be read separately. Efficacy and tolerability both differ substantially between them and summaries routinely blur the two.
Went looking for independent results on this and found a handful across the whole site. That is the honest state of the evidence.
Are you comparing against a GLP-1 monotherapy result? They are not comparable.
Do you have the publication or a summary of it?
amylin and GLP-1 are not redundant pathways
independent purity data on this compound is thin
Is there any independent purity data on this compound that you have seen?
Push back: the evidence base here is thin enough that a confident ranking against the established compounds is not supportable.
Sent a vial to PeptideMeter because there was almost nothing on file for this compound. 98.6% against a claimed 98.0%, and I posted it because the log needs entries.